Eledon Pharmaceuticals Inc (ELDN)
Net Income Growth
-182.01%
Quarterly · Period ending:
ELDN Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-182.01%period ending
Latest reported-182.01%period ending
ELDN Quarterly Net Income YoY % (-89.90% → -182.01%)
Year-over-year change
High-resolution chart · PNG
ELDN net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -182.0078% | |
| -500.8468% | |
| 76.5852% | |
| -122.6826% | |
| 75.0239% | |
| 72.5149% | |
| -363.5051% | |
| 877.0139% | |
| 31.7108% | |
| -119.3743% | |
| 83.5126% | |
| 5.3959% | |
| -611.1496% | |
| -9.2052% | |
| -563.0025% | |
| -6.6619% | |
| -25.2302% | |
| -16.0607% | |
| -49.1531% | |
| -59.7819% | |
| -185.5375% | |
| -3.9379% | |
| -42.471% | |
| -112.3747% | |
| 36.819% | |
| -67.5271% | |
| 9.401% | |
| 17.2483% | |
| -28.3474% | |
| -73.9487% | |
| -116.7773% | |
| -17.7104% | |
| 52.1315% | |
| -104.2213% | |
| 43.5376% | |
| -45.9459% | |
| -564.8703% | |
| 87.9748% | |
| 66.0797% | |
| 82.8314% | |
| 88.8132% | |
| 13.8311% | |
| -77.4646% | |
| -85.493% | |
| -53.0849% | |
| -173.5713% | |
| -12.362% | |
| -89.896% |